Mr Mathias Winkler

Mr Mathias (Matt) Winkler is a Consultant Urological Surgeon with a dual appointment at Imperial College Healthcare NHS Trust (Charing Cross Hospital) and Chelsea and Westminster Hospital NHS Foundation Trust. He is also a Visiting Reader at Imperial College London. He specialises in the diagnosis and treatment of prostate cancer and also treats general urological conditions.

He has performed every form of radical prostatectomy, from open and perineal to laparoscopic and robotic. For the past ten years he has operated exclusively robotically. He is a high-volume lead surgeon, performing 50 to 80 robotic prostatectomies a year, including surgery for locally advanced prostate cancer. He pioneered day-case prostatectomy at Imperial in [2010].

He modernised Imperial’s prostate cancer pathway to MRI-led targeted biopsy, starting in [2011]. He introduced focal therapy and HIFU to Imperial and performed the first in-bore MRI-guided HIFU in the UK.

He chaired the Imperial prostate cancer MDT for 12 years. He now chairs the Chelsea and Westminster MDT for all urological cancers at West Middlesex University Hospital. He is a member of the Imperial Prostate research group at Charing Cross. His research focuses on validating biomarkers and medical technologies, image analysis, and machine learning and AI-driven care pathways.

He qualified in medicine at the University of Magdeburg in 1992, with an intercalated BSc in Biochemistry, after a biomedical exchange at New York Medical College. He completed his MD at the Bristol Urological Institute and his FRCS (Urol) in 2005. He then trained in laparoscopic urological surgery with Professor Stolzenburg in Leipzig. He was previously Training Programme Director for urology in North London and remains committed to surgical training.

He was a trustee of The Mulberry Centre, a cancer support charity, for 12 years until 2026. His patients value clear explanations and time to discuss their options. He speaks English and German.